← back to search

John Blenis

Cornell University · US
Area of research
Molecular Biology · Cancer Research
Research interest
The Blenis lab studies biochemical mechanisms that coordinate extracellular cues, intracellular signaling pathways, and metabolic processes to regulate cellular bioenergetics and redox regulation, mRNA metabolism, protein synthesis and gene expression. The lab has helped to define major signaling pathways, including Ras/ERK/RSK and PI3K/Akt and has performed extensive analyses of mTOR, a checkpoint kinase that deftly integrates signals emanating from growth factors and environmental conditions to guide cellular decisions. These studies have supported the identification of cancer-associated biomarkers and therapeutic targets including several kinases and metabolic enzymes.
h-index
113
citations
68,271
works
337
NIH funding
primary concept
Biology
email

Recent publications

Direct sensing of dietary ω-6 linoleic acid through FABP5-mTORC1 signaling
Science 2025cited by 34position: lastdoi
The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer
Cell Metabolism 2025cited by 20position: lastdoi
The intrinsic substrate specificity of the human tyrosine kinome
Nature 2024cited by 137position: middledoi
Nutrient control of growth and metabolism through mTORC1 regulation of mRNA splicing
Molecular Cell 2024cited by 18position: middledoi
An atlas of substrate specificities for the human serine/threonine kinome
Nature 2023cited by 679position: middledoi
Balancing lysosome abundance in health and disease
Nature Cell Biology 2023cited by 57position: lastdoi
FAM120A couples SREBP-dependent transcription and splicing of lipogenesis enzymes downstream of mTORC1
Molecular Cell 2023cited by 30position: middledoi
Altered propionate metabolism contributes to tumour progression and aggressiveness
Nature Metabolism 2022cited by 107position: lastdoi
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication
Science Signaling 2022cited by 97position: middledoi
Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression
Nature Communications 2022cited by 64position: lastdoi
Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells
Science Advances 2022cited by 49position: lastdoi
Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment
Science Signaling 2022cited by 43position: lastdoi
Prolonged deprivation of arginine or leucine induces PI3K/Akt-dependent reactivation of mTORC1
Journal of Biological Chemistry 2022cited by 26position: middledoi
Targeting mTOR in the Context of Diet and Whole-body Metabolism
Endocrinology 2022cited by 16position: lastdoi
mTORC1 promotes cell growth via m6A-dependent mRNA degradation
Molecular Cell 2021cited by 115position: lastdoi
mTORC1-chaperonin CCT signaling regulates m <sup>6</sup> A RNA methylation to suppress autophagy
Proceedings of the National Academy of Sciences 2021cited by 70position: middledoi
Age-induced accumulation of methylmalonic acid promotes tumour progression
Nature 2020cited by 245position: lastdoi
Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability
Nature Communications 2020cited by 81position: lastdoi
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization
Cancer Cell 2019cited by 100position: lastdoi
ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation
Proceedings of the National Academy of Sciences 2019cited by 97position: middledoi
p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration
Journal of Biological Chemistry 2019cited by 34position: middledoi
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
Nature Cell Biology 2018cited by 1,592position: middledoi
Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization
Cancer Cell 2018cited by 196position: middledoi
mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-Dependent Foxk1 Phosphorylation
Molecular Cell 2018cited by 146position: lastdoi
Beyond the Warburg Effect: How Do Cancer Cells Regulate One-Carbon Metabolism?
Frontiers in Cell and Developmental Biology 2018cited by 111position: middledoi
Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells
Cell 2018cited by 111position: middledoi
Female Sex and Gender in Lung/Sleep Health and Disease: Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung Disease
American Journal of Respiratory and Critical Care Medicine 2018cited by 99position: middledoi
<i>EIF1AX</i> and <i>RAS</i> Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC
Cancer Discovery 2018cited by 91position: middledoi
Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling
Cell 2017cited by 211position: lastdoi
TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
Cell 2017cited by 94position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

John M. Asara · Harvard University9 papers (2013–2022)Lewis C. Cantley · Meyer (China)9 papers (2013–2022)Gina Lee · University of California, Irvine9 papers (2014–2024)Sungyun Cho · Korea University9 papers (2017–2025)Ana P. Gomes · Moffitt Cancer Center8 papers (2015–2022)Michal J. Nagiec · Cornell University7 papers (2018–2025)Vivien Low · Memorial Sloan Kettering Cancer Center7 papers (2018–2025)Long He · Kunming University of Science and Technology6 papers (2017–2025)Zhongchi Li · Cornell University6 papers (2022–2025)Anders P. Mutvei · Karolinska Institutet6 papers (2019–2023)Tanya Schild · Memorial Sloan Kettering Cancer Center5 papers (2018–2022)Sarah‐Maria Fendt · VIB-KU Leuven Center for Cancer Biology5 papers (2013–2022)Noah Dephoure · Arup Group (United States)5 papers (2017–2023)Sang-Oh Yoon · Illinois College5 papers (2014–2019)Edouard Mullarky · Cornell University4 papers (2016–2022)Didem Ilter · Moffitt Cancer Center4 papers (2014–2022)Yonghao Yu · Southwestern Medical Center4 papers (2013–2018)Adam Rosenzweig · Tri-Institutional PhD Program in Chemical Biology4 papers (2018–2022)Gwen R. Buel · National Institutes of Health4 papers (2013–2022)Jennifer E. Endress · Weill Cornell Medicine3 papers (2020–2022)